BSC
UTHR icon

BOLTON SECURITIES CORPORATION’s United Therapeutics UTHR Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$440K Buy
+742
New +$370K 0.02% 575
2025
Q3 		$298K Buy
+710
New +$239K 0.01% 649
2025
Q1 		$353K Buy
+1,146
New +$393K 0.02% 565

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's UTHR Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in United Therapeutics (UTHR) in Q1 2026: 742 shares worth $440K. The stake represents 0.02% of the portfolio and ranks #575 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in UTHR as recently as Q3 2025.

BOLTON SECURITIES CORPORATION first reported a position in UTHR in Q1 2025 and has held it in 3 quarters since. 860 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • BOLTON SECURITIES CORPORATION held 742 shares of United Therapeutics worth $440K as of Q1 2026.
  • United Therapeutics was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
  • United Therapeutics made up 0.02% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #575 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in United Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • 860 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.